Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)

Real-time Quote. Real-time Tradegate - 03/23 07:30:15 pm
82.952 EUR   +0.22%
03/22 SANOFI : Genzyme Extends its Multiple Myeloma Journey Partners Progr..
03/22 SANOFI : Registration is Now Open for SMi’s Rapid Microbial De..
03/21 SANOFI : A serious FDA campaign
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Sanofi to Cut 1,500-2,000 Jobs in France - Report

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/15/2012 | 02:11pm CET

French pharmaceutical giant Sanofi SA (SAN.FR, SNY) will disclose cuts of between 1,500 and 2,000 jobs in France on Sept. 25, French newspaper Le Figaro reported Saturday, without citing sources.

The company plans to reduce its 28,000 payroll in France mainly through attrition, the newspaper said.

In July, Sanofi had said it planned to cut jobs at two French units in a bid to preserve the company's profitability, which has been put at risk by recent patent expirations and the economic recession in most of Europe. The company had said it would detail the job cuts in September.

At the time, French Industry Minister Arnaud Montebourg had criticized the company and said he wouldn't tolerate when profitable companies slash jobs.

A Sanofi spokesman didn't return a phone call seeking comments.

Newspaper Web site: http://www.lefigaro.fr

Write to Inti Landauro at inti.landauro@dowjones.com.

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SANOFI
03/22 SANOFI : Genzyme Extends its Multiple Myeloma Journey Partners Program to Cities..
03/22 SANOFI : Registration is Now Open for SMi’s Rapid Microbial Detection Meth..
03/21 SANOFI : A serious FDA campaign
03/21 SANOFI : Announces Results of First-of-Its-Kind Social Experiment Revealing Real..
03/21DJSANOFI'S PRESCRIPTION FOR GROWTH : Drug Sales in the Middle Kingdom
03/20 MANNKIND : Split with Sanofi results in $178.8M revenue for MannKind in 2016
03/20 SANOFI : Disclosure of trading in own shares
03/18 SANOFI : Pakistan has 7m diabetic patients
03/18 SANOFI : Diabetes increases in Pakistan at alarming rate
03/17DJAmgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- Update
More news
Sector news : Pharmaceuticals - NEC
11:53a TEVA PHARMACEUTICAL INDUSTRIES : Pharm says media reports of up to 6,000 layoffs..
03/22 MYLAN : recalls 81,000 EpiPens outside U.S. after reports of failure
03/20 FTSE rises to record close after Article 50 trigger date set
03/17DJPFIZER : Files 8K - Other Events
03/17 SHANGHAI FOSUN PHARMACEUTICAL : Stada lifts forecasts after telling suitors to r..
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
10:46a Flexion spikes 26% on pending Sanofi takeover
03/21 Sanofi, Regeneron sue Amgen over eczema drug
03/21 Aggressive Payers Block Access To PCSK9s
03/20 Valeritas Sets Terms For $60 Million Diabetes Treatment Device IPO
03/20 Novo Nordisk - Another Apple 2013 Story? New Highs Ahead?
Advertisement
Financials (€)
Sales 2017 36 417 M
EBIT 2017 9 302 M
Net income 2017 5 600 M
Debt 2017 4 507 M
Yield 2017 3,68%
P/E ratio 2017 18,16
P/E ratio 2018 17,19
EV / Sales 2017 3,06x
EV / Sales 2018 2,93x
Capitalization 106 941 M
More Financials
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | SAN | FR0000120578 | 4-Traders
Full-screen chart
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 82,2 €
Spread / Average Target -0,73%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Olivier Brandicourt Chief Executive Officer & Director
Serge Weinberg Chairman
Jérôme Contamine Chief Financial Officer & EVP-Finance
Elias E. Zerhouni President-Global Research & Development
Yong-Jun Liu Head-Global Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
SANOFI7.63%115 490
JOHNSON & JOHNSON9.59%342 277
ROCHE HOLDING LTD.7.52%217 164
PFIZER INC.6.13%205 273
NOVARTIS AG0.47%194 072
MERCK & CO., INC.7.86%174 344
More Results